The generic version of Lamictal XR is an anticonvulsant drug which is indicated for the treatment of epilepsy.
Intellipharmaceutics CEO Isa Odidi said their Hypermatrix technology platform continues to assess its ability to replicate the release profiles of a cross section of drugs and they will continue to seek to exploit the capabilities of this platform to expand their pipeline of products in various stages of development.
The company manufactures generic controlled-release and targeted-release oral solid dosage drugs.